These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34121560)

  • 1. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
    Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
    Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model.
    Cao J; Cheng J; Xi S; Qi X; Shen S; Ge Y
    Eur J Pharm Biopharm; 2019 Apr; 137():112-121. PubMed ID: 30779979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
    Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
    Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin alleviated dextran sulfate sodium-induced colitis by recovering memory Th/Tfh subset balance.
    Zheng LX; Guo KE; Huang JQ; Liu MH; Deng BL; Liu DY; Zhou BG; Zhou W; Zhong YB; Zhao HM
    World J Gastroenterol; 2023 Sep; 29(36):5226-5239. PubMed ID: 37901446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
    Zhou X; Liu Y; Wang X; Li X; Xiao B
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles.
    Ling K; Wu H; Neish AS; Champion JA
    J Control Release; 2019 Feb; 295():174-186. PubMed ID: 30557649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
    Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
    Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of porous starch-loaded bilayer microgels for controlled drug delivery and treatment of ulcerative colitis.
    Wen Z; Kang L; Fu H; Zhu S; Ye X; Yang X; Zhang S; Hu J; Li X; Chen L; Hu Y; Yang X
    Carbohydr Polym; 2023 Aug; 314():120887. PubMed ID: 37173037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
    Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
    Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
    Xiao B; Si X; Zhang M; Merlin D
    Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis.
    Xu H; Luo R; Dong L; Pu X; Chen Q; Ye N; Qi S; Han X; Nie W; Fu C; Hu Y; Zhang J; Gao F
    Nanomedicine; 2022 Jan; 39():102461. PubMed ID: 34562656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.
    Xu W; Su W; Xue Z; Pu F; Xie Z; Jin K; Polyakov NE; Dushkin AV; Su W
    Pharm Res; 2021 Apr; 38(4):693-706. PubMed ID: 33754258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
    Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
    Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine.
    Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q
    Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and β-cyclodextrin-curcumin inclusion complex.
    Roozbehi S; Dadashzadeh S; Mirshahi M; Sadeghizadeh M; Sajedi RH
    Int J Biol Macromol; 2020 Oct; 160():1029-1041. PubMed ID: 32479931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
    Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
    Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges.
    Li S; Zhang H; Chen K; Jin M; Vu SH; Jung S; He N; Zheng Z; Lee MS
    Drug Deliv; 2022 Dec; 29(1):1142-1149. PubMed ID: 35384787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.